2001
DOI: 10.1016/s0009-8981(00)00396-x
|View full text |Cite
|
Sign up to set email alerts
|

Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…Compared to myoglobin and creatine-kinase-MB, cTnI is more sensitive and specific to acute myocardial infarction (AMI) [ 2 ]. As such, it has been recommended as a fundamental cardiac marker for the diagnosis of AMI [ 3 ]. Therefore, developing a convenient assay for cTnI detection, in line with rapid and accurate early detection requirements, is very useful for heart-disease prevention.…”
Section: Introductionmentioning
confidence: 99%
“…Compared to myoglobin and creatine-kinase-MB, cTnI is more sensitive and specific to acute myocardial infarction (AMI) [ 2 ]. As such, it has been recommended as a fundamental cardiac marker for the diagnosis of AMI [ 3 ]. Therefore, developing a convenient assay for cTnI detection, in line with rapid and accurate early detection requirements, is very useful for heart-disease prevention.…”
Section: Introductionmentioning
confidence: 99%
“…These markers have high sensitivity and high negative predictive value. A combined analysis of these two markers can discern injury to the myocardium after AMI onset . Therefore, the myoglobin-specific monoclonal primary antibody antimyoglobin 7C3 and H-FABP-specific monoclonal primary antibody anti-H-FABP 10E1 were, respectively, coupled with azo compounds (for the detailed information on their synthesis, see the Supporting Information).…”
Section: Resultsmentioning
confidence: 99%
“…A combined analysis of these two markers can discern injury to the myocardium after AMI onset. 46 Therefore, the myoglobin-specific monoclonal primary antibody antimyoglobin 7C3 and H-FABP-specific monoclonal primary antibody anti-H-FABP 10E1 were, respectively, coupled with azo compounds (for the detailed information on their synthesis, see the Supporting Information). To prevent azo groups from wrapping in the biomacromolecules as well as to decrease nonspecific biofouling during the immunoassay, 47 a long PEG spacer was introduced in the azo compound structure before the primary cardiac antibodies were grafted onto them.…”
Section: Nucleophilic Substitution Of Terminal Bromide Groupsmentioning
confidence: 99%
“…Furthermore, a combined analysis of these two markers can specifically discern an injury to the myocardium after AMI onset. 20,21 Therefore these two markers are suitable for an early rapid screening test for an AMI diagnosis with a high sensitivity and a high negative predictive value. 22 The technique commonly used for the analysis of disease biomarkers is an immunoassay based on the reaction between an antibody to the biomarker and the antigen (biomarker) itself.…”
mentioning
confidence: 99%
“…In this case, the use of smaller proteins would lead to earlier detection. , Studies have shown that myoglobin (17.8 kDa) and FABP (15 kDa) are two relatively small proteins that show elevated levels in the bloodstream shortly after an acute myocardial infarction. Furthermore, a combined analysis of these two markers can specifically discern an injury to the myocardium after AMI onset. , Therefore these two markers are suitable for an early rapid screening test for an AMI diagnosis with a high sensitivity and a high negative predictive value …”
mentioning
confidence: 99%